Showing results (131-140 of 140) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 140 results.
Annals of the New York Academy of Sciences|May 7, 2009
Relaxin family peptides and receptors in mammalian brainAndrew L Gundlach, Sherie Ma, Qian Sang, et al.
Scientific Reports|July 12, 2024
Retinal hyperspectral imaging in mouse models of Parkinson's disease and healthy agingPaul Trlin, Jenny Gong, Katie K N Tran, et al.
Nature Medicine|January 31, 2012
Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron exportPeng Lei, Scott Ayton, David I Finkelstein, et al.
Chemical Science|August 21, 2018
Correction: Visualising mouse neuroanatomy and function by metal distribution using laser ablation-inductively coupled plasma-mass spectrometry imagingBence Paul, Dominic J Hare, David P Bishop, et al.
Chemical Science|August 21, 2018
Correction: Visualising mouse neuroanatomy and function by metal distribution using laser ablation-inductively coupled plasma-mass spectrometry imagingBence Paul, Dominic J Hare, David P Bishop, et al.
Chemical Science|February 17, 2018
Visualising mouse neuroanatomy and function by metal distribution using laser ablation-inductively coupled plasma-mass spectrometry imagingBence Paul, Dominic J Hare, David P Bishop, et al.
The Journal of Biological Chemistry|October 29, 2011
Diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (CuII(atsm)) protects against peroxynitrite-induced nitrosative damage and prolongs survival in amyotrophic lateral sclerosis mouse modelCynthia P W Soon, Paul S Donnelly, Bradley J Turner, et al.
Neuron|July 11, 2008
Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial AbetaPaul A Adlard, Robert A Cherny, David I Finkelstein, et al.
Acta Neuropathologica Communications|June 30, 2017
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's diseaseDavid I Finkelstein, Jessica L Billings, Paul A Adlard, et al.
The Journal of Experimental Medicine|April 5, 2012
The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson's diseaseLin W Hung, Victor L Villemagne, Lesley Cheng, et al.
Pageof 14